Brief: Bausch Health Companies Inc Says Bausch Health (Excluding. B+L) Confirms 2023 Guidance
May 4 (Reuters) - Bausch Health Companies Inc BHC.TO :
* BAUSCH HEALTH (EXCLUDING. B+L) CONFIRMS 2023 GUIDANCE
* FIRST-QUARTER REVENUES OF $1.94 BILLION, UP 1% REPORTED
AND 4%
ORGANIC
* SEES FULL YEAR REVENUE RANGE OF $8.35 - $8.55 BILLION
* SEES FULL YEAR ADJUSTED EBITDA RANGE OF $3.00 - $3.15
BILLION
* GAAP LOSS PER SHARE ATTRIBUTABLE TO BAUSCH HEALTH FOR THE
FIRST
QUARTER OF 2023 WAS $0.55
* Q1 EARNINGS PER SHARE VIEW $0.72, REVENUE VIEW $1.96
BILLION --
REFINITIV IBES DATA
* FY2023 REVENUE VIEW $8.35 BILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:
Further company coverage: BHC.TO
((Reuters.Brief@thomsonreuters.com;))
Recent news on Bausch Health Companies
See all newsBausch + Lomb CEO Saunders departs, Chairman Appio named interim chief (updated)
Brief: Bausch + Lomb And Bausch Health Announce Appointment Of Thomas J. Appio As Interim Bausch + Lomb CEO, Expect To Raise Full-Year 2026 Guidance
Bausch + Lomb CEO Saunders steps down, Chairman Appio appointed interim chief
Brief: Bausch Health Companies -Co And Yun Expand Strategic Collaboration In Mexico And EMEA Markets
Canada Stocks: Toronto stocks near record high as investors weigh earnings, US PPI data